Search
for

    Sort by

    Research 30 of 41

    1. Establishment of a murine cGVHD model with scleroderma Junshi yixue · 2011
    2. Chronic graft versus host disease and skin Journal of the European Academy of Dermatology and Venereology · 2003 · 32 citations
    3. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease Croatian Medical Journal · 2016 · 17 citations
    4. Human placental mesenchymal stromal cell‐derived exosome‐enriched extracellular vesicles for chronic cutaneous graft‐versus‐host disease: A case report Journal of Cellular and Molecular Medicine · 2021 · 13 citations
    5. Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children Journal of The American Academy of Dermatology · 2018 · 7 citations
    6. Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients American Journal of Clinical Dermatology · 2018 · 5 citations
    7. Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib JAMA Dermatology · 2018 · 4 citations
    8. Permanent alopecia as a manifestation of chronic graft-versus-host disease of the scalp: clinical, dermoscopic and histopathological observations Clinical and Experimental Dermatology · 2018 · 2 citations
    9. Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient Transplantation direct · 2021
    10. Chronic graft-versus-host disease – the role of dermatological treatment Dermatology Review · 2017
    11. Targeting the Hypoxic Microenvironment in Cutaneous Chronic Graft-Versus-Host Disease through PI3Kδ Inhibition Blood · 2024 · 1 citations
    12. Gingerol ameliorates chronic graft-versus-host disease by regulating treg/Th17 transdifferenciation Blood · 2025
    13. Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin Biology of blood and marrow transplantation · 2013
    14. Combination Of Regulatory T Cells and Rapamycin As Treatment For Experimental Chronic Graft-Versus-Host Disease Blood · 2013
    15. Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease Biology of blood and marrow transplantation · 2013 · 47 citations
    16. Vitiligo and Alopecia Areata After Donor Lymphocyte Infusions in a Child With Relapsed Acute Myeloid Leukemia Cureus · 2024
    17. Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia Supportive Care in Cancer · 2022 · 5 citations
    18. General Dermatology Springer eBooks · 2017
    19. Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood Bone Marrow Transplantation · 2017 · 16 citations
    20. Role of umbilical cord mesenchymal stromal cells in skin rejuvenation npj Regenerative Medicine · 2024 · 10 citations
    21. New small molecules in dermatology: for the autoimmunity, inflammation and beyond Inflammation Research · 2023 · 9 citations
    22. Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease Curēus · 2023 · 2 citations
    23. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    24. Potential therapeutic applications of mesenchymal stem cell-derived extracellular vesicles DiRROS repository (University of Maribor) · 2026
    25. Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need! American Journal of Clinical Dermatology · 2026
    26. Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-II 2024
    27. Hair repigmentation associated with the use of brentuximab JAAD Case Reports · 2017 · 15 citations
    28. Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report Journal of Medical Case Reports · 2010 · 4 citations
    29. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019 · 277 citations
    30. SYK inhibitor entospletinib prevents ocular and skin GVHD in mice JCI Insight · 2018 · 45 citations